NRIX vs UBER · rev $54.5M vs P/E 18, rev $52.02B
Nurix Therapeutics Inc (NRIX) versus Uber Technologies Inc (UBER) — a side-by-side from cached financials, not a winner call.
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
Uber Technologies Inc (UBER) is a software - application company listed on NYSE. It is led by Dara Khosrowshahi.
Latest reported NRIX revenue for 2024-11-30 was $54.5M. Net income was -$193.6M. Revenue was down 29.1% from 2023-11-30 to 2024-11-30. NRIX currently screens at market cap $1.77B.
Latest reported UBER revenue for 2025-12-31 was $52.02B. Net income was $10.05B. Revenue was up 18.3% from 2024-12-31 to 2025-12-31. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
NRIX currently screens at market cap $1.77B. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
Not investment advice. Open the NRIX and UBER stock pages for the full models.
Not investment advice.